QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Tilray Brands, Inc. (TLRY)

Healthcare

No action
Fundamental
2
Sentiment
2
Technical
2

Do Nothing: fundamentalScore is 2 and qualitativeScore is 2 — both below the required floor of 3; strategy requires fundamentalScore >= 3 AND qualitativeScore >= 3 before any bullish entry.

Analysis as of 2026-10-16· more than 2 trading days ago

Company overview

Tilray Brands, Inc. is a global consumer packaged goods company focused on cannabis cultivation, processing, marketing, and sales. It operates in Canada, the U.S., Europe, Australia, New Zealand, and Latin America, with divisions in Cannabis, Distribution, Beverage Alcohol, and Wellness. The company offers a range of cannabis products and also distributes pharmaceutical and wellness goods, as well as alcoholic beverages.

Fundamental

weak
Fundamental2
Weak fundamentals

Tilray's fundamentals are weak, with persistent losses, negative free cash flow, and structural dilution.

Weak, stabilization-stage fundamentals: five straight loss years and negative free cash flow funded by persistent share issuance, with covenant relief, a June 2027 convertible maturity and fresh regulatory/tariff risks keeping pressure on. Offsets - revenue growth, positive adjusted EBITDA, ~$221M liquidity and a nominal net-cash position without going-concern or default - are real but not yet enough; a speculative, watchlist-only profile.

Sentiment

weak
Sentiment2
Bearish sentiment

Market sentiment is bearish following a negative reception to recent earnings and ongoing dilution concerns.

Dominant in-window driver is the Q1 FY2027 print (2026-10-08; confidence: announced): record revenue and reaffirmed EBITDA guidance offset by a consensus revenue miss, a swing to loss, a ~4% print-day selloff and follow-on target cuts (TD, Canaccord) — net-negative market reception. Sentiment delta shows no corroborated improvement (flat-to-softly-negative, item-level determinate read, moderate confidence — baseline ≈ -0.06 across 18 scored items; the degraded scoring window's only scored item is the issuer's own +0.6 PR), and the Red-Flag Screen fired no severe or moderate flags (no caps applied), leaving a bearish-tilted, non-actionable digestion setup.

Technical

weak
Technical2
Strong downtrend

The stock is in a strong downtrend with oversold conditions but no trend repair.

Chart quality 2/5 — weak bearish, bounce-only. TLRY trades below its SMA20 (3.74), SMA50 (4.18) and SMA200 (5.83) and below EMA9 (3.43)/EMA21 (3.69), with the 50-day under the 200-day; MACD (-0.26/-0.21/-0.05) remains below zero and below signal; ADX14 28.5 and rising alongside the decline reads as a strong, still-active down trend. RSI14 28.0 and Williams %R -86.4 are oversold and produced a single-session bounce off the 3.07 52-week low, but no trend repair has occurred (price has not reclaimed the EMA9/EMA21 stack). No actionable bullish structure; any pullback/oversold limit bid here would be countertrend (price < SMA50 with MACD < 0), and no settled breakout level clears the falling EMA stack. Independent of the chart, the trade is hard-blocked: fundamentalScore 2 and qualitativeScore 2 both fall below the required floor of 3, so no bullish entry is permitted and no trade plan was evaluated (Step 03 skipped per the hard-block procedure).

You’re looking at 2026-10-16 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.